Loading…
Zai Lab Limited is projected to rise to $25.29 by 2027, a +23% move from its current price of $20.49. ZLAB is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $20.11 | $20.50 | $20.90 | +0.06% |
| Jul 13 | $19.96 | $20.51 | $21.08 | +0.12% |
| Jul 14 | $19.85 | $20.53 | $21.22 | +0.18% |
| Jul 15 | $19.76 | $20.54 | $21.34 | +0.24% |
| Jul 16 | $19.69 | $20.55 | $21.45 | +0.30% |
| Jul 17 | $19.62 | $20.56 | $21.55 | +0.36% |
| Jul 18 | $19.56 | $20.58 | $21.65 | +0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $19.56 | $20.58 | $21.65 | +0.41% |
| Week 2 | $19.23 | $20.66 | $22.20 | +0.83% |
| Week 3 | $19.00 | $20.75 | $22.66 | +1.25% |
| Week 4 | $18.82 | $20.83 | $23.06 | +1.67% |
| Week 5 | $18.67 | $20.92 | $23.44 | +2.09% |
| Week 6 | $18.55 | $21.01 | $23.79 | +2.52% |
| Week 7 | $18.44 | $21.09 | $24.13 | +2.94% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Zai Lab Limited is a biopharmaceutical company that focuses on discovering, developing, and commercializing products that address medical conditions in oncology, immunology, neuroscience, and infectious diseases.
Its commercial portfolio includes Zejula, an orally administered PARP1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer.
The company has strategic collaborations with Tesaro, Inc., NovoCure Ltd., Deciphera Pharmaceuticals, LLC, Paratek Bermuda Ltd., argent BV, Turning Point Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Karuna Therapeutics, Inc., Pfizer Inc., Amgen Inc., and with Boehringer Ingelheim GmbH. The company was incorporated in 2013 and is based in Pudong, China.
Zai Lab Limited trades at $19.98 and has a market capitalization of $2.26B. It holds the rank of 1964 in market capitalization.
The longer-term price outlook is bullish, with a forecast path showing rising averages across the years. The 2026 forecast is neutral with a 2026 average of $19.98 and a range from $16.30 to $27.23, while later years project higher averages and greater upside, including a 2030 average of $30.70 and a 2050 average of $152.25.
Forecasted maximums rise from $27.23 in 2026 to $41.95 in 2030, $130.00 in 2040, and $249.99 in 2050, reflecting substantial upside potential over the long term.
A major floor 26.1% below — a decisive break under it would weaken the trend.
The nearest floor, 19.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 23.2% above — clearing it would confirm fresh momentum.
Key ZLAB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ZLAB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.73 | Buy | $19.85 | Buy |
| MA 10 | $19.23 | Buy | $19.39 | Buy |
| MA 20 | $18.62 | Buy | $18.93 | Buy |
| MA 50 | $18.83 | Buy | $18.95 | Buy |
| MA 100 | $19.48 | Buy | $19.56 | Buy |
| MA 200 | $20.93 | Sell | $21.46 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 69.51 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 179.23 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.27 | Buy |
| ROC (12) | 10.82 | Buy |
| Bollinger %B (20,2) | 1.05 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.10 | Buy |
| Awesome (5,34) | 1.52 | Buy |
| Ultimate (7,14,28) | 87.38 | Sell |
| Momentum (10) | 1.97 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 20.21 | Buy |
| ADX (14) | 18.03 | Neutral |
| ATR (14) | 0.32 | Info |
The 30-day technical picture is bullish. RSI(14) is 70, and the price action is supported by a 50-day simple moving average of $18.86 and a 200-day simple moving average of $20.99.
Key levels include support at $16.48 and resistance at $19.98, with a 30-day trading range from $17.61 to $22.66.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.30 | $20.49 | $28.05 | 0% | Neutral | |
| $20.69 | $25.29 | $32.35 | +23% | Bullish | |
| $21.55 | $26.85 | $35.29 | +31% | Bullish | |
| $24.48 | $30.98 | $41.60 | +51% | Bullish | |
| $25.75 | $33.04 | $45.17 | +61% | Bullish | |
| $29.01 | $37.69 | $52.35 | +84% | Bullish | |
| $35.49 | $46.64 | $65.73 | +128% | Bullish | |
| $37.97 | $50.44 | $72.01 | +146% | Bullish | |
| $42.22 | $56.65 | $81.86 | +176% | Bullish | |
| $44.78 | $60.66 | $88.65 | +196% | Bullish | |
| $68.23 | $96.49 | $147.87 | +371% | Bullish | |
| $116.10 | $176.41 | $290.08 | +761% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $16.30 | $20.49 | $24.61 | +0.00% |
| August 2026 | $18.36 | $21.50 | $25.73 | +4.93% |
| September 2026 | $18.38 | $21.63 | $26.09 | +0.58% |
| October 2026 | $18.34 | $21.68 | $26.32 | +0.23% |
| November 2026 | $18.86 | $22.36 | $27.31 | +3.18% |
| December 2026 | $19.21 | $22.85 | $28.05 | +2.18% |
Click any year to see its month-by-month ZLAB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ZLAB could reach as high as $28.05, with a base case around $20.49 and support toward $16.30 — roughly 0% from $20.49. Price action looks broadly range-bound.
Expect ZLAB to range from $20.69 to $32.35 through 2027. The $25.29 average target implies a +23% move from current prices. That is up +23% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The ZLAB price prediction for 2028 points to an average of $26.85 (low $21.55, high $35.29) — a potential gain of +31% on today's $20.49. Momentum favours further upside here.
In 2029, ZLAB is projected to trade between $24.48 and $41.60, averaging $30.98 — a potential gain of +51% from today's $20.49. That is up +15% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Zai Lab Limited's 2030 outlook centres on $33.04, within a $25.75 to $45.17 range. That is up +7% on the projected 2029 average. That marks a +61% change versus current levels. Momentum favours further upside here.
By 2031, ZLAB could reach as high as $52.35, with a base case around $37.69 and support toward $29.01 — roughly +84% from $20.49. Buyers look set to stay in control over this stretch.
Expect ZLAB to range from $35.49 to $65.73 through 2032. The $46.64 average target implies a +128% move from current prices. That is up +24% on the projected 2031 average. Momentum favours further upside here.
The ZLAB price prediction for 2033 points to an average of $50.44 (low $37.97, high $72.01) — a potential gain of +146% on today's $20.49. Buyers look set to stay in control over this stretch.
In 2034, ZLAB is projected to trade between $42.22 and $81.86, averaging $56.65 — a potential gain of +176% from today's $20.49. That is up +12% on the projected 2033 average. Momentum favours further upside here.
Zai Lab Limited's 2035 outlook centres on $60.66, within a $44.78 to $88.65 range. That is up +7% on the projected 2034 average. That marks a +196% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ZLAB could reach as high as $147.87, with a base case around $96.49 and support toward $68.23 — roughly +371% from $20.49. Momentum favours further upside here.
Expect ZLAB to range from $116.10 to $290.08 through 2050. The $176.41 average target implies a +761% move from current prices. That is up +83% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ZLAB today (≈ 48.804295 ZLAB) could be worth
$8,609.74
+$7,609.74 (+761%) by 2050 · US Dollar
Based on the average projected ZLAB price of $176.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ZLABwould be worth at today's price.
$1,000 invested in ZLAB on Jul 10, 2025 (≈ 29.342721 ZLAB) would be worth
$601.23
-$398.77 (-39.9%) today · 0.60× · US Dollar
Based on a ZLAB entry price of $34.08 vs. today's $20.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $19.12 | $1,071.65 | +7.2% |
| 1 month ago | $17.26 | $1,187.14 | +18.7% |
| 3 months ago | $20.68 | $990.81 | -0.9% |
| 6 months ago | $18.39 | $1,114.19 | +11.4% |
| 1 year ago | $34.08 | $601.23 | -39.9% |
| All time (5.0y) ago | $172.42 | $118.84 | -88.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ZLAB forecast.
Our base-case forecast reaches $41.00 around 2032.
Implied market cap at $41.00: $4.63B
The multi-year forecast shows meaningful upside across the horizon. By 2030 the average price is projected to be $30.70 with a maximum of $41.95 and a minimum of $23.94, corresponding to an ROI of 53.7 and a bullish sentiment. By 2040 the average rises to $84.93 with a max of $130.00 and an ROI of 325.1, continuing the bullish trend.
By 2050 the average is projected at $152.25 with a max of $249.99 and an ROI of 662, maintaining a strong bullish stance.
The sentiment in the forecast remains bullish from 2027 onward, with 2027–2035 showing rising averages and continued upside, while 2026 is neutral. These projections imply substantial upside potential but are estimates, not guarantees, and depend on future factors such as regulatory outcomes, clinical results, and market conditions.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $30.70, with a min of $23.94 and a max of $41.95, and an ROI of 53.7.
Forecasts indicate upside over the period, with bullish sentiment from 2027 onward and higher projected averages through 2035–2050. However, the 2026 outlook is neutral and these figures are estimates, not guarantees.
Yes. The forecast for 2050 shows an avg of $152.25 and a max of $249.99, indicating the potential to exceed $100 in the long term.
The current price is $19.98.
RSI(14) is 70, with SMA50 at $18.86 and SMA200 at $20.99. The 30-day range is $17.61 to $22.66, with support at $16.48 and resistance at $19.98.
Zai Lab Limited Community Discussion
0Share your Zai Lab Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.